Haemolytic anaemia after oral artemether–lumefantrine treatment in a patient affected by severe imported falciparum malaria

• DOI: 10.1007/s15010-013-0451-x
• Publication Date: 2013-04-03T06:21:40Z
• Authors: P. De Nardo; A. Oliva; M. L. Giancola; P. Ghirga; P. Mencarini; M. Bibas; E. Nicastri; A. Antinori; A. Corpolongo
• Keywords: Male; 0301 basic medicine; Anemia, Hemolytic; Fluorenes; Artemether, Lumefantrine Drug Combination; Administration, Oral; Middle Aged; Artemisinins; 3. Good health; Antimalarials; Drug Combinations; 03 medical and health sciences; Ethanolamines; Humans; Malaria, Falciparum

Artemisinin and its derivatives are essential components of artemisinin-based combination therapies for treating severe falciparum malaria. In this paper, we describe the occurrence of haemolysis after oral artemether-lumefantrine treatment. To the best of our knowledge, this is the second reported case of a patient affected by severe falciparum malaria with haemolytic anaemia that is likely associated with oral artemether-lumefantrine treatment.